E-LIB Suche - Ergebnisse für: Din, Jenny Min

1

423. Biomarkers of Auditory Information Processing and Neur..:

Joshi, Yash ; Gonzalez, Christopher ; Zoleikhaeian, Daniel...
Biological Psychiatry. 95 (2024) 10 - p. S273 , 2024

Link: https://doi.org/10.1016/..

2

271. Can Amphetamine Augment Gains From Targeted Cognitive ..:

Swerdlow, Neal ; Talledo, Jo ; Din, Jenny Min...
Biological Psychiatry. 93 (2023) 9 - p. S203 , 2023

Link: https://doi.org/10.1016/..

3

562. Memantine Augmentation of Targeted Cognitive Training ..:

Light, Gregory ; Din, Jenny Min ; Minhas, Jessica...
Biological Psychiatry. 93 (2023) 9 - p. S321 , 2023

Link: https://doi.org/10.1016/..

4

481. Explaining Variance in Auditory Targeted Cognitive Tra..:

Joshi, Yash ; Gonzalez, Christopher ; Molina, Juan...
Biological Psychiatry. 93 (2023) 9 - p. S289 , 2023

Link: https://doi.org/10.1016/..

5

210. Feasibility and Reliability of a Combined Virtual Real..:

Bhakta, Savita ; Gonzalez, Christopher ; Wu, Yue...
Biological Psychiatry. 93 (2023) 9 - p. S178-S179 , 2023

Link: https://doi.org/10.1016/..

6

Mismatch negativity predicts initial auditory-based targete..:

Joshi, Yash B. ; Gonzalez, Christopher E. ; Molina, Juan L....
Psychiatry Research. 327 (2023) - p. 115215 , 2023

Link: https://doi.org/10.1016/..

7

Temporary treatment cessation versus continuation of first-..:

Brown, Janet E ; Royle, Kara-Louise ; Gregory, Walter...
The Lancet Oncology. 24 (2023) 3 - p. 213-227 , 2023

Link: https://doi.org/10.1016/..

8

Temporary treatment cessation versus continuation of first-..:

Brown, Janet E ; Royle, Kara-Louise ; Gregory, Walter...
STAR Investigators , Brown , J E , Royle , K-L , Gregory , W , Ralph , C , Maraveyas , A , Din , O , Eisen , T , Nathan , P , Powles , T , Griffiths , R , Jones , R , Vasudev , N , Wheater , M , Hamid , A , Waddell , T , McMenemin , R , Patel , P , Larkin , J , Faust , G , Martin , A , Swain , J , Bestall , J , McCabe , C , Meads , D , Goh , V , Min Wah , T , Brown , J , Hewison , J , Selby , P & Collinson , F 2023 , ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ' , Lancet Oncology , vol. 24 , no. 3 , pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8. , 2023

Link: https://pure.qub.ac.uk/e..

9

Temporary treatment cessation versus continuation of first-..:

Brown, Janet ; Royle, Kara-Louise ; Gregory, Walter...
Brown , J , Royle , K-L , Gregory , W , Ralph , C , Maraveyas , A , Din , O , Eisen , T , Nathan , P , Powles , T , Griffiths , R , Jones , R , Vasudev , N , Wheater , M , Hamid , A , Waddell , T , McMenemin , R , Patel , P , Larkin , J , Faust , G , Martin , A , Swain , J , Bestall , J , McCabe , C , Meads , D , Goh , V , Wah , T M , Brown , J , Hewison , J , Selby , P & Collinson , F 2023 , ' Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial ' , The Lancet Oncology , vol. 24 , no. 3 , pp. 213-227 . https://doi.org/10.1016/S1470-2045(22)00793-8. , 2023

Link: https://kclpure.kcl.ac.u..

10